Language
The woman behind AstraZeneca’s cancer winning streak

News

HomeHome / News / The woman behind AstraZeneca’s cancer winning streak
search
RECENT NEWS

Jan 24, 2024

San Angelo Suspects Arrested for Stealing Copper from HVAC Business

Jan 27, 2024

Made in Connecticut: Kongsberg Automotive » CBIA

May 19, 2023

Crews battling fire at Cascade Die Casting

May 22, 2023

Sheet metal manufacturer breaks ground on new facility in Seguin

Aug 01, 2023

What tool steel and coating are best for stamping lamination steel?

SEND YOUR INQUIRY
SUBMIT

Aug 16, 2023

The woman behind AstraZeneca’s cancer winning streak

By Matthew Herper June 6, 2023 CHICAGO — It was the kind of moment scientists

By Matthew Herper June 6, 2023

CHICAGO — It was the kind of moment scientists who develop new medicines wait their entire careers to experience. On Sunday, thousands of oncologists applauded after researchers presented data on AstraZeneca's Tagrisso. When given after surgery to the right lung cancer patients, selected using genetic tests, it cut the death rate in half.

Benjamin J. Solomon of the Peter MacCallum Cancer Center, called to the stage at the American Society of Clinical Oncology's annual conference, said the result "opens up a new chapter for precision medicine with targeted therapy in early stage non-small cell lung cancer."

advertisement

Susan Galbraith, who heads AstraZeneca's oncology research and development, was watching from the audience. "It was a great day," she said.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

Senior Writer, Medicine, Editorial Director of Events

Matthew Herper covers medical innovation — both its promise and its perils.

ASCO23

cancer

drug development

pharmaceuticals

STAT+